# Amphastar Pharmaceuticals, Inc. – FDA Inspection, Feb 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/b297f414-5cd0-46c7-a3cf-138b1f5293af
Source feed: FDA_Inspections

> FDA inspection 1079028 of Amphastar Pharmaceuticals, Inc., February 12, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079028
- Company Name: Amphastar Pharmaceuticals, Inc.
- Inspection Date: 2019-02-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1290538 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/84de8825-ab9e-4fa3-a9c3-56d089df0daa)
- [FDA Inspection 1266798 - 2025-04-03](https://www.keypedia.com/records/fda_inspections/amphastar-pharmaceuticals-inc/f3a88961-407c-4d84-af4c-f19faea69e77)
- FDA Inspection 1229403 - 2024-03-01
- FDA Inspection 1144508 - 2021-06-22
- FDA Inspection 1113865 - 2019-11-22

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- [Issuing Officer](https://www.keypedia.com/people/philip-f-istafanos/c2fcfe52-1070-4551-bffc-f8bcfad5b30b)

Company: https://www.keypedia.com/companies/amphastar-pharmaceuticals-inc/e90eb882-5679-4c85-bbc8-f69ca69cc537

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b